Addex Therapeutics (ADXN) EPS (Basic) (2023 - 2025)
Historic EPS (Basic) for Addex Therapeutics (ADXN) over the last 3 years, with Q3 2025 value amounting to -$0.01.
- Addex Therapeutics' EPS (Basic) rose 4584.71% to -$0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 million, marking a year-over-year decrease of 8543.12%. This contributed to the annual value of $100.8 million for FY2024, which is 6466232719659.12% up from last year.
- Per Addex Therapeutics' latest filing, its EPS (Basic) stood at -$0.01 for Q3 2025, which was up 4584.71% from -$0.02 recorded in Q2 2025.
- Addex Therapeutics' 5-year EPS (Basic) high stood at -$0.01 for Q2 2024, and its period low was -$138.5 million during Q4 2024.
- For the 3-year period, Addex Therapeutics' EPS (Basic) averaged around -$12.8 million, with its median value being -$0.02 (2025).
- Per our database at Business Quant, Addex Therapeutics' EPS (Basic) tumbled by 10235620144495.63% in 2024 and then surged by 4584.71% in 2025.
- Quarter analysis of 3 years shows Addex Therapeutics' EPS (Basic) stood at -$0.14 in 2023, then plummeted by 102356201444.96% to -$138.5 million in 2024, then skyrocketed by 100.0% to -$0.01 in 2025.
- Its EPS (Basic) was -$0.01 in Q3 2025, compared to -$0.02 in Q2 2025 and -$1.6 million in Q1 2025.